Home › Autism Spectrum Disorder › NCT03718923
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
The Seaver Autism Center for Research and Treatment - Assessment Core
Who can join
Ages 2 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Eligible participants must have a documented variant affecting the FOXP1 gene that the research team determines to be likely or definitely pathogenic. * Eligible participants must be at least 2 years of age. Exclusion Criteria: * none
About the study
FOXP1, also known as Forkhead-box Protein P1, is a transcription factor protein belonging to the FOX gene family. Disruptions in the FOXP1 gene cause a phenotype characterized by global developmental delay, speech deficits, mild dysmorphic features, and traits of autism spectrum disorder. This study seeks to characterize FOXP1-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures.
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 50 · Started: Mar 28, 2016
Contact the study team
- Hailey Silver · Phone: (212) 241- 6231
- Tess Levy · Phone: 212-241-5290
Official record on ClinicalTrials.gov — NCT03718923
Locations in the U.S.
| New York | The Seaver Autism Center for Research and Treatment, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.